Skip to main content
VCbacked
Log inGet Started

Atomo Diagnostics

Leichhardt, Australia

Atomo Diagnostics design and manufactures blood-based, lateral flow rapid diagnostic test (RDT) devices.

$1.6M raised
Oct 2024
Grant
BiotechnologyHealth CareManufacturingMedical Device

Top Investors

Bill & Melinda Gates FoundationDepartment of IndustryInnovation and ScienceGrand Challenges CanadaSydney AngelsGlobal Health Investment Fund (GHIF)

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Atomo Diagnostics

How much funding has Atomo Diagnostics raised?
Atomo Diagnostics has raised $1.6M in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Who are Atomo Diagnostics's investors?
Atomo Diagnostics's investors include Bill & Melinda Gates Foundation, Department of Industry, Innovation and Science, Grand Challenges Canada, Sydney Angels, Global Health Investment Fund (GHIF).
Where is Atomo Diagnostics headquartered?
Atomo Diagnostics is headquartered in Leichhardt, Australia.
What does Atomo Diagnostics do?
Atomo Diagnostics design and manufactures blood-based, lateral flow rapid diagnostic test (RDT) devices.
What stage is Atomo Diagnostics at?
Atomo Diagnostics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Atomo Diagnostics — Funding & Investors." VCBacked, October 22, 2024, https://www.vcbacked.co/company/atomo-diagnostics. Accessed July 5, 2026.
APA
VCBacked. (2024). Atomo Diagnostics — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/atomo-diagnostics
Wikipedia (cite web)
{{cite web |title=Atomo Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/atomo-diagnostics |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K